SEARCH

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    Novo Nordisk to cut 9,000 jobs: Ozempic maker to reduce workforce by 11%; refocus on diabetes and obesity treatments

    9 hours ago

    Novo Nordisk is set to reduce its workforce by 11%, eliminating 9,000 jobs globally, including 5,000 in Denmark, to save $1.3 billion amid rising competition for its obesity treatments. This restructuring follows a lowered earnings forecast and aims to streamline operations for growth in diabetes and obesity markets. Shares rose despite the announcement.
    Click here to Read more
    Prev Article
    Mutual funds trends: Equity inflows drop 22% to Rs 33,430 cr in August; SIP momentum flat at Rs 27,000 cr
    Next Article
    India not pursuing dollar alternative: CEA Nageswaran clarifies on economic conditions; assures resilience amid global tensions

    Related Business Updates:

    Comments (0)

      Leave a Comment